A phase II study of the dual mTOR inhibitor MLN0128 in patients with metastatic castration resistant prostate cancer.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Tamara L Lotan Howard I. Scher |
| Publication date | March 6, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |